Business Description
Jacobio Pharmaceuticals Group Co Ltd
ISIN : KYG4987A1094
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.33 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | -0.56 | |||||
Altman Z-Score | -1.64 | |||||
Beneish M-Score | -1.73 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -61 | |||||
3-Year EBITDA Growth Rate | 53.8 | |||||
3-Year Book Growth Rate | -19 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.17 | |||||
9-Day RSI | 25.41 | |||||
14-Day RSI | 28.17 | |||||
6-1 Month Momentum % | -3.75 | |||||
12-1 Month Momentum % | -53.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6 | |||||
Quick Ratio | 6 | |||||
Cash Ratio | 5.87 | |||||
Days Payable | 1309.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | -2.53 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 3.45 | |||||
Operating Margin % | -1624.06 | |||||
Net Margin % | -1549.41 | |||||
FCF Margin % | -1429.42 | |||||
ROE % | -33.38 | |||||
ROA % | -24.79 | |||||
ROIC % | -109.67 | |||||
ROC (Joel Greenblatt) % | -159.4 | |||||
ROCE % | -27.87 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 37.27 | |||||
PB Ratio | 1 | |||||
Price-to-Tangible-Book | 1 | |||||
EV-to-EBIT | -0.15 | |||||
EV-to-EBITDA | -0.15 | |||||
EV-to-Revenue | 2.25 | |||||
EV-to-FCF | -0.16 | |||||
Price-to-Net-Current-Asset-Value | 1.34 | |||||
Price-to-Net-Cash | 1.4 | |||||
Earnings Yield (Greenblatt) % | -666.67 | |||||
FCF Yield % | -37.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Jacobio Pharmaceuticals Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 25.359 | ||
EPS (TTM) (HK$) | -0.505 | ||
Beta | 0.95 | ||
Volatility % | 48.61 | ||
14-Day RSI | 28.17 | ||
14-Day ATR (HK$) | 0.087558 | ||
20-Day SMA (HK$) | 1.41 | ||
12-1 Month Momentum % | -53.33 | ||
52-Week Range (HK$) | 1.23 - 3.71 | ||
Shares Outstanding (Mil) | 788.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jacobio Pharmaceuticals Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jacobio Pharmaceuticals Group Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Jacobio Pharmaceuticals Group Co Ltd Frequently Asked Questions
What is Jacobio Pharmaceuticals Group Co Ltd(HKSE:01167)'s stock price today?
When is next earnings date of Jacobio Pharmaceuticals Group Co Ltd(HKSE:01167)?
Does Jacobio Pharmaceuticals Group Co Ltd(HKSE:01167) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |